LMHRA LMHRA-R-[PV-24-001],LMHRA-R-[PV-24-001], Version 001
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
LMHRA-R-[PV-24-001], Version 001 is the official LMHRA identifier for “Regulations on Pharmacovigilance in Liberia”. LMHRA-R-[PV-24-001], Version 001 is the official identifier LMHRA uses for this instrument.
- Instrument
- LMHRA-R-[PV-24-001],
- Full name
- LMHRA-R-[PV-24-001], Version 001
- Category
- Vigilance
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Regulations on Pharmacovigilance in Liberia
Selected medical-device and IVD provisions from the 43-page LMHRA Regulations on Pharmacovigilance in Liberia: identity and complete definitions, the reporting-duty list and patient/provider/manufacturer roles, the full device-vigilance and falsified-product clauses, and common offences, review and appeal provisions. Fifteen physical pages contain the selected text; this is not the complete regulation or annex inventory. Section 9(1)(c) leaves device reporting requirements and timelines to applicable device-control and vigilance rules; clinical ADR and cosmetic deadlines are not general device deadlines. The cover and citation state 28 May 2025, while the signed final page records submission on 26 September 2024 and Board approval on 3 October 2024 with immediate-effect wording. These dates and medicine-centric definitions remain unresolved; no single effective date or currentness conclusion is asserted.
LMHRA-R-[PV-24-001], Version 001 is the official identifier LMHRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.